These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 34519230)
41. Microbicidal Polymer Nanoparticles Containing Clotrimazole for Treatment of Vulvovaginal Candidiasis. Del Rocío Lara-Sánchez M; Ganem-Rondero A; Nava-Arzaluz MG; Becerril-Osnaya AA; Pérez-Carranza LA; Alcalá-Alcalá S; Mendoza-Muñoz N; Piñón-Segundo E AAPS PharmSciTech; 2024 Aug; 25(7):197. PubMed ID: 39174702 [TBL] [Abstract][Full Text] [Related]
42. Formulation and evaluation of butenafine loaded PLGA-nanoparticulate laden chitosan nano gel. Alshehri S; Imam SS Drug Deliv; 2021 Dec; 28(1):2348-2360. PubMed ID: 34747275 [TBL] [Abstract][Full Text] [Related]
43. Development and characterization of voriconazole loaded nanoparticles for parenteral delivery. Füredi P; Kovács K; Ludányi K; Antal I; Klebovich I Int J Pharm; 2016 Aug; 510(1):159-63. PubMed ID: 27291972 [TBL] [Abstract][Full Text] [Related]
44. Voriconazole-Loaded Nanostructured Lipid Carriers for Ocular Drug Delivery. Andrade LM; Rocha KA; De Sá FA; Marreto RN; Lima EM; Gratieri T; Taveira SF Cornea; 2016 Jun; 35(6):866-71. PubMed ID: 27055213 [TBL] [Abstract][Full Text] [Related]
45. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B. Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145 [TBL] [Abstract][Full Text] [Related]
46. Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity. Veloso DFMC; Benedetti NIGM; Ávila RI; Bastos TSA; Silva TC; Silva MRR; Batista AC; Valadares MC; Lima EM Drug Deliv; 2018 Nov; 25(1):1585-1594. PubMed ID: 30044149 [TBL] [Abstract][Full Text] [Related]
47. Antifungal Effects of Voriconazole-Loaded Nano-Liposome on Fluconazole Hassanpour P; Hamishehkar H; Bahari Baroughi B; Baradaran B; Sandoghchian Shotorbani S; Mohammadi M; Shomali N; Aghebati-Maleki L; Nami S Assay Drug Dev Technol; 2021 Oct; 19(7):453-462. PubMed ID: 34435891 [No Abstract] [Full Text] [Related]
48. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation. Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442 [TBL] [Abstract][Full Text] [Related]
49. Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment. Pawar P; Kashyap H; Malhotra S; Sindhu R Biomed Res Int; 2013; 2013():341218. PubMed ID: 23762839 [TBL] [Abstract][Full Text] [Related]
50. Nanosuspension as an Efficient Carrier for Improved Ocular Permeation of Voriconazole. Qin T; Dai Z; Xu X; Zhang Z; You X; Sun H; Liu M; Zhu H Curr Pharm Biotechnol; 2021; 22(2):245-253. PubMed ID: 32867650 [TBL] [Abstract][Full Text] [Related]
51. Development and characterization of the voriconazole loaded lipid-based nanoparticles. Füredi P; Pápay ZE; Kovács K; Kiss BD; Ludányi K; Antal I; Klebovich I J Pharm Biomed Anal; 2017 Jan; 132():184-189. PubMed ID: 27750101 [TBL] [Abstract][Full Text] [Related]
52. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation. Rençber S; Karavana SY; Şenyiğit ZA; Eraç B; Limoncu MH; Baloğlu E Pharm Dev Technol; 2017 Jun; 22(4):551-561. PubMed ID: 27055376 [TBL] [Abstract][Full Text] [Related]
53. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Gupta M; Vyas SP Chem Phys Lipids; 2012 May; 165(4):454-61. PubMed ID: 22309657 [TBL] [Abstract][Full Text] [Related]
54. Stimuli-Responsive in situ Spray Gel of Miconazole Nitrate for Vaginal Candidiasis. Hsin YK; Thangarajoo T; Choudhury H; Pandey M; Meng LW; Gorain B J Pharm Sci; 2023 Feb; 112(2):562-572. PubMed ID: 36096286 [TBL] [Abstract][Full Text] [Related]
55. Development and Characterization of Nisin Nanoparticles as Potential Alternative for the Recurrent Vaginal Candidiasis Treatment. de Abreu LC; Todaro V; Sathler PC; da Silva LC; do Carmo FA; Costa CM; Toma HK; Castro HC; Rodrigues CR; de Sousa VP; Cabral LM AAPS PharmSciTech; 2016 Dec; 17(6):1421-1427. PubMed ID: 26810491 [TBL] [Abstract][Full Text] [Related]
56. Improved skin delivery of voriconazole with a nanostructured lipid carrier-based hydrogel formulation. Song SH; Lee KM; Kang JB; Lee SG; Kang MJ; Choi YW Chem Pharm Bull (Tokyo); 2014; 62(8):793-8. PubMed ID: 25087631 [TBL] [Abstract][Full Text] [Related]
57. p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis. Ferreira PS; Victorelli FD; Rodero CF; Fortunato GC; Araújo VHS; Fonseca-Santos B; Bauab TM; Van Dijck P; Chorilli M Int J Pharm; 2021 Jun; 603():120658. PubMed ID: 33964336 [TBL] [Abstract][Full Text] [Related]
58. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers. Rizwanullah M; Amin S; Ahmad J J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665 [TBL] [Abstract][Full Text] [Related]
59. In vivo study of hypericin-loaded poloxamer-based mucoadhesive in situ gelling liquid crystalline precursor system in a mice model of vulvovaginal candidiasis. de Araújo PR; Calixto GMF; Araújo VHS; Sato MR; Rodero CF; Oshiro-Junior JA; Bauab TM; Chorilli M Med Mycol; 2021 Jul; 59(8):821-827. PubMed ID: 33626136 [TBL] [Abstract][Full Text] [Related]
60. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats. Thirupathi G; Swetha E; Narendar D Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]